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ABSTRACT
The airway smooth muscle is the key determinant of airway narrowing in asthma but its function in the absence
of disease is unknown. Evidence for an intrinsic abnormality in the muscle in asthma is only just emerging. The
airway smooth muscle is not merely a contractile cell, but also one which determines the composition of, and
interacts with the extracellular matrix, and which may participate in inflammatory and allergic reactions and viral
infections. The reason for the differences which have been observed in the in vitro properties of airway smooth
muscle derived from asthmatic individuals may result from an inherent “supercontractility”, an increased ten-
dency to proliferate due to the absence of an inhibitory transcription factor CEBP-α, the influence of an altered
extracellular matrix andor a decrease in release of factors such as PGE2 which would under normal circum-
stances inhibit both proliferation and contraction. Although long acting beta agonists and corticosteroids are
successful treatments for inflammation and bronchoconstriction, the structural changes which constitute airway
remodelling may require additional therapeutic intervention, the nature of which will be determined by thorough
investigation of the mechanisms underlying the asthmatic phenotype.
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INTRODUCTION
The association between airway smooth muscle and
asthma has been acknowledged for nearly a hundred
years, in that excessive contraction of the muscle was
known to form the basis of the exaggerated airway
narrowing which is an integral part of an asthma “at-
tack”. With the recent advances made in understand-
ing the biology of the airway smooth muscle cell, its
role as simply a contractile element has expanded
into that of a cell which can also modulate the im-
mune response, affect airway remodelling, and con-
tribute significantly to the pathology of airways dis-
ease. The airway smooth muscle cell is the target for
many therapeutic regimens, and has been shown to
respond both in vivo and in vitro to anti-inflammatory
agents such as corticosteroids , and to bronchodila-
tors such as β2-agonists. Given that increased airway
smooth muscle mass is a consistent finding in the
asthmatic remodelling process, this cell has become
the focus of research for many groups world wide.
It is interesting however to speculate on the func-
tion of the airway smooth muscle in the non- diseased
airway. It appears to serve little purpose either in
terms of playing a role in inhalation or exhalation, as-
sisting the propulsion of mucus, optimising ventila-
tionperfusion relationships or protecting the periph-
eral lung from noxious particlesallergens. Mitzner
has therefore suggested that the airway smooth mus-
cle is vestigial and likens it to the appendix―assum-
ing importance only in the diseased state.1
The importance of the smooth muscle in asthma
has recently been emphasised by the investigation of
the use of thermoplasty―i.e. the delivery of thermal
energy via a bronchoscope to target the airway
smooth muscle. Initial experiments in dogs revealed
that the ensuing reduction in smooth muscle mass re-
sulted in an increase in airway size whether the air-
way was contracted or relaxed2 and a reduction in air-
way hyperresponsiveness . 3 Preliminary studies in
non asthmatic humans have established feasibility
and safety.4 Recently, in a study of 16 subjects with
mild to moderate asthma5 thermoplasty was well tol-
erated and produced improvements in airway hyper-
responsiveness which were maintained for 2 years .
Whether thermoplasty will become a widely accepted
therapeutic intervention for remains to be seen.
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THE AIRWAY SMOOTH MUSCLE CELL AND
CONTRACTION
The nature of the essential abnormality which causes
contraction of airway smooth muscle in an asthmatic
subject in response to stimuli as diverse as allergens,
occupational triggers, cold air etc while these have no
effect in a nonasthmatic subject, remains unknown.
Attempts to prove that the muscle is “supercontrac-
tile” have met with little success, in that the opportu-
nities to conduct contractile studies on asthma-
derived muscle are rare and the results of the few
studies that do exist vary from demonstrating in-
creased contractility to decreased contractility to de-
creased relaxation to no clear differences.6-10
Several theories proposing a contractile dysfunc-
tion have been proposed. The difference in response
of asthmatics and nonasthmatics to deep inspiration
(DI) following bronchoconstriction has provided a
stimulus for much discussion.11 DI in nonasthmatic
patients produces prolonged bronchodilatation ,
whereas this effect is diminished in patients with
asthma . The reasons for this difference are not
known but could be the result of stiffer airways in
asthmatic patients, or perhaps an increased propen-
sity for the asthmatic airways to renarrow after dilata-
tion.
The contraction of airway smooth muscle is de-
pendent on activation of actin and myosin cross-
bridges and the phosphorylation of myosin light
chain by myosin light chain kinase. The degree to
which myosin light chain is phosphorylated can de-
termine the velocity of shortening and maximum con-
traction and there is a possibility that this may be al-
tered by the coexistence of allergy or sensitisation.
Recently Ma et al.12 have attempted to show that a
phenomenon that exists in canine isolated airway
smooth muscle cells viz the presence of supercon-
tractile muscle cells13 occurs in humans. They found
that single cells isolated from asthmatic subjects con-
tracted to a greater extent and more quickly than
muscle cells from non asthmatic subjects. Moreover
there was increased messenger RNA for myosin light
chain kinase in the asthmatic cells, which they hy-
pothesise explains their findings. More studies such
as these are needed to confirm that asthmatic muscle
is intrinsically hypercontractile.
THE AIRWAY SMOOTH MUSCLE CELL AND
ALLERGY
The link between asthma and allergy is well estab-
lished but the role of the airway smooth muscle cell
in allergic events is controversial . Almost 20 years
ago it was noted that muscle tissue derived from
atopic nonasthmatic subjects exhibited different in vi-
tro contractile properties compared with muscle from
non atopic controls.14 Mast cell derived tryptase po-
tentiated contractile responses in tissue derived from
atopic but nonasthmatic subjects but not that ob-
tained from nonatopic subjects, and the mechanisms
appeared to be calcium dependent.15 In addition the
incubation of human airway smooth muscle rings in
serum from highly atopic asthmatic patients― so-
called passive sensitisation- altered contractile and re-
laxation responses to a wide range of agonists . 16,17
The atopic serum contained high concentrations of
IgE. Incubation of bronchial rings in either high con-
centrations of IgE or atopic serum increased the
number of IgE bearing cells which were identified as
largely mast cells.18 In addition a contractile response
to anti IgE could be elicited in both these situations.
All these findings would lead to a logical conclusion
that IgE itself was the agent responsible for the
changes in contractile and relaxant properties. More-
over human airway smooth muscle cells have been
shown to constitutively express Fc epsilon R1.19 How-
ever Watson et al . demonstrated convincingly that
IgE was not the factor responsible for the increased
responsiveness induced in vitro by passive sensitisa-
tion.20 Tunon de Lara has speculated that specific IgG
may play a contributory role, as could the presence of
inflammatory cell derived proteases and cytokines
such as stem cell factor and tryptase.21 It is of interest
that the anti-human IgE antibody (omalizumab) has
been demonstrated to have beneficial effects as an
add on therapy in several clinical studies but it is un-
likely that these can be related to effects on the air-
way smooth muscle cell.
THE AIRWAY SMOOTH MUSCLE CELL AND
INFLAMMATION
Airway smooth muscle cells are a key component of
the inflammatory milieu, and have the ability to syn-
thesise a vast repertoire of cytokines , chemokines
and other inflammatory mediators, such as RANTES,
eotaxin, IL-1β, IL-5, IL-6, IL-8, IL-11, MCP-1, MCP-2,
MCP-3, GM-CSF, IFN-β, leukaemia inhibitory factor,
and prostanoids such as prostaglandin E2 (PGE2).22
Many of these factors are produced in response to
stimulation with proinflammatory cytokines such as
TNF-α, INF-γ, and IL-1β, and since these factors are
found to be elevated in the airways of asthmatic pa-
tients, in vitro stimulation is likely to reflect the in-
flammatory cascade present within the asthmatic air-
way. In addition many cytokine and chemokine re-
ceptors are present upon the surface of these cells,
suggesting that both autocrine and paracrine signal-
ing control airway smooth muscle function in vivo
(see Fig. 1).
Antigen presentation is function which is generally
considered to be restricted to so called professional
antigen presenting (APC) cells (macrophages, den-
dritic cells and B lymphocytes) of the immune sys-
tem. Given that airway smooth muscle cells can ex-
press MHC class II,23 and the co-stimulatory mole-
cules CD80 and CD86,24 it is surprising that they ap-
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Fig. 1 A diagrammatic representation of the potential autocrine 
feedback loops which exist within human smooth muscle cels. For 
example, eotaxin which is produced both constitutively and in re-
sponse to a diverse range of stimuli such as mast cel adhesion, 
cigarete smoke, and other cytokines such as IL-4 and 13 can po-
tentialy activate CCR3 upon smooth muscle cels to induce the re-
lease of other cytokines and/or their receptors and to mediate 
chemotaxis of surounding smooth muscle cels.
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pear unable to act as antigen presenting cells. How-
ever as alveolar macrophages from only asthmatic
subjects are able to function as APC,25 it remains to
be determined if the same is true of asthmatic muscle
cells. Airway smooth muscle cells do however pos-
sess the ability to function as a cell of the innate im-
mune system since they express, and respond to liga-
tion of, several Toll-like receptors.26
Eosinophils bind to smooth muscle cells, adhesion
is modulated by TNF-α and is also mediated through
ICAM-1 and VCAM-1.27 Mast cells are found to local-
ise within smooth muscle bundles in vivo, however,
the mechanism by which mast cells are recruited and
adhere to smooth muscle cells is not known. It is hy-
pothesised that the elevated cytokine and chemokine
production observed in asthma, in combination with
smooth muscle derived stem cell factor (SCF)28 could
provide a mechanism by which mast cell numbers
within smooth muscle bundles are elevated in asth-
matic subjects . Recently Brightling et al . have re-
ported that the chemokine CXCL10 ( IP-10) is ex-
pressed preferentially in the muscle of asthmatic pa-
tients and ex vivo asthma derived smooth muscle
cells. Together with the fact that the chemokine re-
ceptor CXCR3 was preferentially expressed on mast
cells located in the muscle, this constitutes a mecha-
nism for the attraction of the mast cells to the mus-
cle.29 The chemokine fractalkine or CX3CL1 which is
also produced by airway smooth muscle cells also
may contribute to mast cell recruitment , especially
when the mast cell are stimulated with vasoactive in-
testinal polypeptide (VIP) . 30 Mast cell adhesion to
smooth muscle cells has recently been shown to be
mediated in part by tumour suppressor in lung
cancer-1 (TSLC1), which is preferentially expressed
upon the surface of human lung mast cells, but not by
ICAM-1, VCAM-1, CD18, and the alpha4 and beta1 in-
tegrins.31 Adhesion of Mast cells to smooth muscle
cells induces the release of eotaxin which is depen-
dant upon p38 MAPK.32 Mast cells located within the
airway bundles of asthmatic subjects produce IL-4
and IL-13.33 IL-4 and IL-13 are T helper 2 cytokines
that are thought to contribute to the pathogenesis of
asthma, and, furthermore, have been shown to have
direct effects upon airway smooth muscle cells, such
as the induction of eotaxin 34 and the reduction of
beta-adrenergic responsiveness by IL-13. 35 In addi-
tion, in vivo degranulation of mast cells correlates to
asthma severity, and the increased degranulation ob-
served in cartilaginous versus membranous bronchi-
oles suggests an inhaled stimulus is activating these
cells.36
Smooth muscle cells express several cell surface
receptors capable of activating and binding other im-
mune cells. ICAM-1 and vascular cell adhesion mole-
cule (VCAM) -1 are constitutively expressed upon the
cell surface and are inducible by pro-inflammatory cy-
tokines such as TNF-α.37 ICAM-1, in addition to be-
ing the cellular receptor for the major groups of rhi-
noviruses, and VCAM-1 can be used by activated T
cells to mediate adhesion. CD44, which is the cellular
receptor for hyaluronan , is also constitutively ex-
pressed upon the surface of smooth muscle cells and
T cells. It is hypothesized that hyaluronan which is
bound to CD44 upon the surface of smooth muscle
cells can act as a binding site for T cell CD44.37 Of
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Fig. 2 A cartoon representing the potential interaction of human airway 
smooth muscle cels and inflammatory cels. The possibility exists for many 
inflammatory cels to interact with smooth muscle cels, which is usualy me
diated via adhesion molecules such as ICAM and VCAM, however compo
nents of the extracelular matrix such as hyaluronan may also act as a bridge 
to mediate binding between smooth muscle cels and inflammatory cels.
Mast cell
CXCR3T cell
CD44
IP-10
fractalkine
TSLC1
ICAM-1/VCAM-1
EosinophilT cell
CD 40 L
CD 40 /OX 40 /
OX 40 L
CD44
hyaluronan
particular importance in the context of asthma, adhe-
sion of T cells to smooth muscle cells induces smooth
muscle proliferation.37 CD40, a member of the TNF
receptor family, is expressed upon the surface of air-
way smooth muscle cells. CD40 binds to a specific
ligand (CD40 L), which is expressed upon the sur-
face of T cells . Direct activation of smooth muscle
CD40 increased intracellular calcium and IL-6 protein
secretion , 38 further indicating the possible impor-
tance of T cell airway smooth muscle interaction. Fur-
ther evidence for the possible interactions between
smooth muscle cells and T cells was provided in a re-
cent report by Burgess et al.. Smooth muscle cells ex-
press OX40 ligand, and furthermore, activation of OX
40 ligand increased the IL-6 release from airway
smooth muscle cells. As OX40 is expressed upon the
surface of T cells activated through T cell receptor
stimulation, this report provides further evidence for
the possible interaction between T cells and smooth
muscle cells in orchestrating the immune response.39
The potential interactions of smooth muscle cells and
inflammatory cells are shown in Figure 2.
AIRWAY REMODELLING AND ASM PROLIF-
ERATION
Airway remodelling is now recognised as a character-
istic feature of severe persistent asthma and includes
increased smooth muscle mass, increased thickening
of the basement membrane, increased new vessel for-
mation and epithelial and mucous cell dysplasia. In-
itial observations indicated that the increase in
smooth muscle was due to cellular hyperplasia, since
a 3 fold increase in nuclei was found.40 A more recent
report which examined the three dimensional struc-
ture of the airways in asthma found that both hyper-
plasia and hypertrophy occur in the large and small
airways respectively . 41 The milieu of cytokines ,
chemokines and matrix proteins produced by the
smooth muscle are thought to provide the conditions
necessary for the increased smooth muscle mass
seen in the asthmatic lung. The ability of cytokines to
stimulate proliferation of airway smooth muscle cells
may to some extent depend upon both the autocrine
and paracrine production of PGE2, which inhibits
DNA synthesis.42 Autocrine production of PGE2 is re-
duced in asthmatic smooth muscle cells,43 providing
a potential mechanism by which accelerated repro-
duction of smooth muscle cells may occur. Produc-
tion of other autocrine mediators such as INF-β also
have been shown to reduce proliferation,44 highlight-
ing the importance of the effect of autocrine inflam-
matory mediators upon the function of the airway
smooth muscle cell.
In addition , intrinsic differences in the smooth
muscle cells between asthmatics and non-asthmatics
now have been discovered . 45,46 In vitro airway
smooth muscle cells from asthmatic subjects prolifer-
ate at a faster rate than non-asthmatic cells,45 produce
greater amounts of proinflammatory cytokines, both
constitutively and induced, and respond differently to
common respiratory drugs. In addition the transcrip-
tion factor CCAATenhancer binding protein α (C
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Fig. 3 Diagrammatic representation of the efects of steroids upon mitogen-induced pro-
liferation of human airway smooth muscle cels. In non-asthmatic cels mitogen-induced 
proliferation is inhibited by steroids, however in asthmatic cels the inhibitory efects of ster-
oids upon proliferation is only observed upon the reintroduction of C/EBPα. ↑represents 
an increase in proliferation, and ↓represents a decrease in proliferation.
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EBPα ) is deficient in airway smooth muscle cells
from asthmatic subjects.46 There are six members of
the CEBP transcription factor family, which not only
regulate cytokine expression, but are involved in cell
cycle regulation and cellular differentiation . 47 C
EBPα inhibits proliferation of many cell types,47 and
in airway smooth muscle cells derived from non-
asthmatic subjects neutralisation of CEBPα using
antisense oligonucleotides reversed the anti prolifera-
tive effects of glucocorticoids. Furthermore the rein-
troduction of CEBPα into smooth muscle cells de-
rived from asthmatic subjects enabled the anit-
proliferative effects of steroids to be observed within
these cells . Since CEBPα is deficient in airway
smooth muscle cells from asthmatic patients , this
provides a potential mechanism by which increased
proliferation occurs(see Fig. 3).
THE AIRWAY SMOOTH MUSCLE CELL AND
THE EXTRACELLULAR MATRIX
The airway smooth muscle cell is surrounded by an
extracellular matrix (ECM)bed. Which consists of
matrix proteins, such as collagen I, II, IV and V, fi-
bronectin, decorin, chondroitin sulfate, elastin, perle-
can, laminin β (1 ) , γ (1 ) ,β (2 ) ,α (1)chains , throm-
bospondin and versican,48 matrix degrading enzymes
MMP 1, 2 and 9, as well as tissue inhibitors of metal-
loproteinases (TIMP)-149 and TIMP-2.50 The interac-
tion between the ECM and the airway smooth muscle
cell can regulate both ECM composition and airway
smooth muscle cell function. The ECM is very dy-
namic, with a turnover rate of 10―15% per day. Degra-
dation of the ECM releases inflammatory modulators
and growth factors that can feed back on the smooth
muscle cell, and in addition the smooth muscle cell
can respond to ECM components through integrins.
Smooth muscle cell proliferation has been shown to
be dependant upon autocrine production of MMP-2,51
and furthermore smooth muscle proliferation in re-
sponse to stimulation with PDGF BB or α-thrombin
is inhibited by laminin whereas fibronectin and colla-
gen I increase cell division(see Fig. 4).52
In vivo differences are observed in the composition
of the ECM in asthma, and in vitro airway smooth
muscle cells from asthmatic subjects produce greater
perlecan and collagen I and decreased collagen IV,
laminin α1, and chondroitin sulfate in comparison to
non-asthmatic cells.53 In addition the signalling path-
ways leading to the deposition of extracellular matrix
proteins from airway smooth muscle cells may be dif-
ferent in asthmatic and nonasthmatic patients.54 Inter-
estingly the relationship between the airway smooth
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Fig. 4 Interactions between the extracelular matrix (ECM) and the smooth muscle 
cels. Complex interactions exist between the ECM and smooth muscle cels, regulat-
ing both matrix deposition and smooth muscle proliferation. Many inflammatory media-
tors are known to bind to components of the ECM which can be released during 
turnover to act upon the smooth muscle cel or other lung cels.
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Fig. 5 A cartoon ilustrating the potential interaction between 
smooth muscle cels and rhinovirus.  Smooth muscle cels constitu-
tively express ICAM-1 which is the celular receptor for the major 
group of rhinovirus.  Binding of rhinovirus to ICAM-1 induces the re-
lease of proinflammatory cytokines, which can then potentialy alter 
the both the contractile response and functional expression of the 
B2 adrenoceptor on the smooth muscle cel.
proinflammatory cytokines
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ICAM-1
Dysfunctional beta adrenoceptor
muscle cell, matrix protein deposition and cytokines
such as vascular endothelial growth factor and con-
nective tissue growth factor may have implications
for the development of the angiogenesis which con-
stitutes a component of the remodelling process.
THE AIRWAY SMOOTH MUSCLE CELL AND
VIRUS INFECTION
The foremost contributor to morbidity, mortality and
health care costs associated with asthma are exacer-
bations, of which at least 70% are associated with viral
infection.
Viruses are pathogens of the lower respiratory
tract, however much controversy surrounds the abil-
ity for airway smooth muscle to become infected with
virus in vivo. Importantly , in situ hybridisation has
demonstrated that both submucosal 55 and smooth
muscle cells,56 can be infected with viruses in-vivo.
Rhinovirus is the most commonly encountered viral
infection producing exacerbations in adult asthmatics
and infection of airway smooth muscle cells has been
demonstrated in vitro. 57 We as well as others have
shown that rhinovirus induced the release of proin-
flammatory cytokines from airway smooth muscle
cells , thereby providing a potential mechanism by
which rhinovirus induced exacerbations occur . 58
There is clinical evidence to support a decreased re-
sponse to beta adrenoceptor agonists during a respi-
ratory virus infection.59 This has led to the hypothesis
that viral infection may cause dysfunction in the beta
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adrenoceptor on the smooth muscle and some pre-
liminary evidence exists in support of this,60 in addi-
tion we have preliminary evidence that rhinovirus in-
duces the release of PGE2 from airway smooth mus-
cle cells, thereby providing a mechanism by which
dysfunction in the beta adrenoceptor occurs(see Fig.
5). 61 Other proposed mechanisms of virus-induced
exacerbations include downregulation of the M2 mus-
carinic on vagal nerve endings62 and modulation of
the endothelin system.63 Conversely, Billington et al.,
2001 suggest that rhinovirus induces sensitisation of
the adenylyl cyclase pathway, leading the authors to
speculate that the increased production of cAMP is a
defensive mechanism designed to promote airway re-
laxation upon infection with rhinovirus.64
The airway smooth muscle cell has many roles in
the airway, from maintaining airway tone to regulat-
ing ECM composition and the local inflammatory and
growth factor milieu. These cells are the therapeutic
targets for drugs used to treat asthma and other air-
way disorders. Since they are intrinsically different in
asthmatic patients they are likely to be intimately in-
volved in the remodelling process and the progres-
sion of the asthmatic phenotype. Their role in airway
disease is only beginning to be understood, and in
the future the interaction of allergens and lower respi-
ratory tract infections with the smooth muscle cell
may yield valuable insights into the pathogenesis of
asthma and other respiratory diseases.
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